Back to search

University of Strathclyde

Design and synthesis of small molecule BET inhibitors

Abstract

dc:description.abstract

Small molecule Bromodomain and Extra-Terminal (BET) inhibitors have shown promising therapeutic interest in oncology and immuno-inflammation. However, clinical studies have shown limited therapeutic window for pan-BET inhibitors, restricting their use to aggressive oncology indications. A macrophage-targeted approach, using the Esterase Sensitive Motif (ESM) technology, is being investigated in our laboratories. The first ESM-BET inhibitor is currently progressing through clinical studies for the treatment of rheumatoid arthritis. This cell-targeted approach has so far demonstrated reduced toxicity in preclinical animal studies. Due to the attrition rate during drug development, a second ESM-BET inhibitor is desired. In this thesis, a novel series of ESM-BET inhibitors is investigated. The initial molecules demonstrated high in vitro clearance in human and monkey species. This was rationalised as due to a lack of carboxyl esterase (CES) selectivity, in particular between CES-1 (desired) and CES-2 (undesired). The current study describes how CES-1 vs. CES-2 selectivity was achieved. Further optimisation efforts led to the discovery of two advanced molecules with suitable profiles for progression into in vivo PK studies. In parallel to the medicinal chemistry optimisation, the synthetic route towards the key benzazepinone motif was improved in terms of yields, step count and robustness, enabling scale up to support investigation of multiple BET inhibitor series within our laboratories. Finally, partial racemisation of two chiral centres was identified during lead optimisation. A stereoselective route was established to address this issue, providing crystalline material in excellent e.e. and good yields throughout the synthetic route to support the progression of the molecules in in vivo studies.

Degree

thesis:*
Name dc:type.qualificationname
phd
Level dc:type.qualificationlevel
doctoral-pg
Grantor dc:publisher.institution
University of Strathclyde
Year dc:date.issued
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Kessedjian, Hripsimée
Advisor dc:contributor.advisor
  • Jamieson, Craig, 1973-
Author Identifier dc:creator.authoridentifier
  • 201691559

Rights

Identifiers

dc:identifier.*
Identifier
T17272

Chain of custody

source
Harvested from
University of Strathclyde
Base URL
stax.strath.ac.uk/catalog/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Kessedjian, Hripsimée. Design and synthesis of small molecule BET inhibitors. doctoral-pg thesis, University of Strathclyde, 2020. https://stax.strath.ac.uk/concern/theses/ww72bc07m